Welcome to the Kimberly Clark 4Q 2024 earningscall. At this time ... that came down to 160-basis-point contribution in Q4. That coincides with inflation tapering off in Argentina as the ...
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.